Condition 1: Stress. Condition 2: Atherosclerotic heart disease. Condition 3: Anexity. Condition 4: Coronary angiography. Acute stress reaction I25.1 Generalized anxiety disorder Medical devices associated with adverse incidents in diagnostic and therapeutic use
Conditions
Interventions
Intervention 1: In the intervention group, patients inhale five drops of 40% Rosa Damascus Essence on absorbent Cloth attached to their collar for 20 minutes. Intervention 2: In the placebo group, p
Treatment - Drugs
Placebo
In the intervention group, patients inhale five drops of 40% Rosa Damascus Essence on absorbent Cloth attached to their collar for 20 minutes.
In the placebo group, patients inhale five drops of distilled water are placed on an absorbent cloth attached to their collar for 20 minutes.
Sponsors
Vice chancellor of research and technology
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Candidate patients for coronary angiography in the angiographic section will be included in the following criteria: (a) first time angiography; (b) lack of critical clinical conditions; (c) non-compliance with angioplasty; (d) lack of alcohol and narcotic addiction; (E) Full person alertness and ability to answer the questioner's questions; (i) Absence of diagnosed anxiety disorder based on the physician's opinion. Patients with the following criteria will be excluded from the study: (a) aromatherapy intolerance for any cause; (b) any disorder or instability in the state of consciousness or hemodynamic Leads to the impossibility of continuing the study; (c) the reluctance to continue to participate in Study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic parameter. Timepoint: Before and after the intervention. Method of measurement: Using a heart monitor and a clock.;Stress. Timepoint: Before and after the intervention. Method of measurement: Using the stress section of the dass questionnaire 21.;Anxiety. Timepoint: Before and after the intervention. Method of measurement: Using the anxiety section of DASS 21 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Bikmoradi
School of public health, Hamadan University of Medical Sciences
Outcome results
None listed